To probe the molecular mechanism by which IGFL2‐AS1 promotes CRC cell function, we identified the gene expression profiles of IGFL2‐AS1 knockdown and control group LoVo cells by RNA sequencing analysis. The gene discussed is IGFL2; the disease is colorectal carcinoma.